Pacira BioSciences Announces Findings From Real-World Study Evaluating Outcomes Associated With Use Of EXPAREL Following Outpatient Total Shoulder Arthroplasty In Medicare Advantage Patients
Pacira Biosciences Inc PCRX
$23.66
▼ -1.58%
($-0.38)
Open
$23.95
Prev Close
$24.04
Day Range
$23.21 – $24.14
52W Range
$18.80 – $27.64
Market Cap
$939.12M
P/E (TTM)
184.04
Beta
0.29
EPS (TTM)
$0.13
📋 Company Profile
| Industry | Pharmaceuticals |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2011-02-03 |
| Shares Out. | 39,350,000 |
| Website | pacira.com/ ↗ |
| Phone | 13026587581 |
Pacira Biosciences Inc is a publicly traded company under the ticker symbol PCRX on the NASDAQ NMS - GLOBAL MARKET, operating in the Pharmaceuticals industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
13 analysts (2026-05-01)